{"entity":{"type":"insider","cik":"0001365615","url":"/insider/0001365615","json_url":"/insider/0001365615.json","name":"Saks Samuel R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":7,"first":"2007-11-14","last":"2016-06-29","span_basis":"filed_date"},"name_variants":[{"name":"Saks Samuel R","source":"filing","n_filings":7,"first_seen":"2007-11-14","last_seen":"2016-06-29"}],"transactions":[{"id":9293147,"accession":"0001615774-16-006118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-16-006118","line_url":"/filing/0001615774-16-006118#line-1","is_derivative":false,"issuer_cik":"0001365615","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001365615","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":51050.0,"shares_owned_after_display":"51,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-21","filed_date":"2016-06-29","scope":"insider"},{"id":2857710,"accession":"0001615774-16-006000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615774-16-006000","line_url":"/filing/0001615774-16-006000#line-1","is_derivative":false,"issuer_cik":"0001365615","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001365615","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":63550.0,"shares_owned_after_display":"63,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-21","filed_date":"2016-06-21","scope":"insider"},{"id":8701208,"accession":"0001144204-15-043095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-043095","line_url":"/filing/0001144204-15-043095#line-1","is_derivative":false,"issuer_cik":"0001365615","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001365615","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":32550.0,"shares_owned_after_display":"32,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-17","filed_date":"2015-07-17","scope":"insider"},{"id":6438587,"accession":"0001209191-14-009866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-009866","line_url":"/filing/0001209191-14-009866#line-1","is_derivative":false,"issuer_cik":"0001365615","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001365615","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director, Officer (Chief Development Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2175.0,"shares_display":"2,175","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":26100.0,"total_display":"26,100.00","total_whole":"26,100","shares_owned_after":63839.0,"shares_owned_after_display":"63,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-12","scope":"insider"},{"id":5351460,"accession":"0001144204-13-046288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-046288","line_url":"/filing/0001144204-13-046288#line-1","is_derivative":false,"issuer_cik":"0001365615","issuer_name":"Tonix Pharmaceuticals Holding Corp.","issuer_ticker":"TNXP","issuer_name_source":null,"issuer_url":"/issuer/0001365615","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5883.0,"shares_display":"5,883","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":22550.0,"shares_owned_after_display":"22,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-15","scope":"insider"},{"id":8396509,"accession":"0001232524-07-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-07-000014","line_url":"/filing/0001232524-07-000014","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"JAZZ PHARMACEUTICALS INC","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":13.396326530612244,"price_display":"13.40","price_state":"stated","total_value":65642.0,"total_display":"65,642.00","total_whole":"65,642","shares_owned_after":347001.0,"shares_owned_after_display":"347,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-14","filed_date":"2007-11-15","scope":"insider","n_lines":2},{"id":8314337,"accession":"0001232524-07-000012","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001232524-07-000012","line_url":"/filing/0001232524-07-000012","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"JAZZ PHARMACEUTICALS INC","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13300.0,"shares_display":"13,300","price_per_share":13.41790977443609,"price_display":"13.42","price_state":"stated","total_value":178458.2,"total_display":"178,458.20","total_whole":"178,458","shares_owned_after":338301.0,"shares_owned_after_display":"338,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-13","filed_date":"2007-11-14","scope":"insider","n_lines":5},{"id":8314323,"accession":"0001232524-07-000012","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001232524-07-000012","line_url":"/filing/0001232524-07-000012","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"JAZZ PHARMACEUTICALS INC","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001365615","owner_name":"Saks Samuel R","owner_display_name":"Saks Samuel R","owner_url":"/insider/0001365615","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10438.0,"shares_display":"10,438","price_per_share":13.412198697068403,"price_display":"13.41","price_state":"stated","total_value":139996.53,"total_display":"139,996.53","total_whole":"139,997","shares_owned_after":323001.0,"shares_owned_after_display":"323,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-12","filed_date":"2007-11-14","scope":"insider","n_lines":10}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001430306","name":"Tonix Pharmaceuticals Holding Corp.","url":"/issuer/0001430306","role":"Director","n_filings":4,"first_seen":"2013-08-15","last_seen":"2016-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001454189","name":"Auspex Pharmaceuticals, Inc.","url":"/issuer/0001454189","role":"Director, Officer (Chief Development Officer)","n_filings":1,"first_seen":"2014-02-12","last_seen":"2014-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"JAZZ PHARMACEUTICALS INC","url":"/issuer/0001232524","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2007-11-14","last_seen":"2007-11-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001365615","retrieved_at":"2026-08-25T20:36:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}